vs
Side-by-side financial comparison of BCB BANCORP INC (BCBP) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $26.2M, roughly 1.2× BCB BANCORP INC). RxSight, Inc. runs the higher net margin — -28.1% vs -49.7%, a 21.6% gap on every dollar of revenue. On growth, BCB BANCORP INC posted the faster year-over-year revenue change (13.1% vs -18.9%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 1.8%).
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
BCBP vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $26.2M | $32.6M |
| Net Profit | $-12.0M | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | -71.9% | -34.8% |
| Net Margin | -49.7% | -28.1% |
| Revenue YoY | 13.1% | -18.9% |
| Net Profit YoY | -467.6% | -54.1% |
| EPS (diluted) | $-0.73 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.2M | $32.6M | ||
| Q3 25 | $26.5M | $30.3M | ||
| Q2 25 | $25.2M | $33.6M | ||
| Q1 25 | $23.8M | $37.9M | ||
| Q4 24 | $23.1M | $40.2M | ||
| Q3 24 | $26.2M | $35.3M | ||
| Q2 24 | $20.4M | $34.9M | ||
| Q1 24 | $25.3M | $29.5M |
| Q4 25 | $-12.0M | $-9.2M | ||
| Q3 25 | $4.3M | $-9.8M | ||
| Q2 25 | $3.6M | $-11.8M | ||
| Q1 25 | $-8.3M | $-8.2M | ||
| Q4 24 | $3.3M | $-5.9M | ||
| Q3 24 | $6.7M | $-6.3M | ||
| Q2 24 | $2.8M | $-6.1M | ||
| Q1 24 | $5.9M | $-9.1M |
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 70.1% |
| Q4 25 | -71.9% | -34.8% | ||
| Q3 25 | 21.9% | -40.1% | ||
| Q2 25 | 19.9% | -41.6% | ||
| Q1 25 | -49.2% | -28.2% | ||
| Q4 24 | 19.9% | -21.5% | ||
| Q3 24 | 35.7% | -26.1% | ||
| Q2 24 | 19.5% | -23.9% | ||
| Q1 24 | 33.0% | -36.2% |
| Q4 25 | -49.7% | -28.1% | ||
| Q3 25 | 16.1% | -32.4% | ||
| Q2 25 | 14.2% | -35.0% | ||
| Q1 25 | -35.0% | -21.6% | ||
| Q4 24 | 14.1% | -14.8% | ||
| Q3 24 | 25.5% | -17.9% | ||
| Q2 24 | 13.8% | -17.4% | ||
| Q1 24 | 23.2% | -30.8% |
| Q4 25 | $-0.73 | $-0.22 | ||
| Q3 25 | $0.22 | $-0.24 | ||
| Q2 25 | $0.18 | $-0.29 | ||
| Q1 25 | $-0.51 | $-0.20 | ||
| Q4 24 | $0.17 | $-0.14 | ||
| Q3 24 | $0.36 | $-0.16 | ||
| Q2 24 | $0.14 | $-0.16 | ||
| Q1 24 | $0.32 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $304.3M | $275.7M |
| Total Assets | $3.3B | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $228.1M | ||
| Q3 25 | — | $227.5M | ||
| Q2 25 | — | $227.5M | ||
| Q1 25 | — | $229.3M | ||
| Q4 24 | — | $237.2M | ||
| Q3 24 | — | $237.1M | ||
| Q2 24 | — | $233.3M | ||
| Q1 24 | — | $125.4M |
| Q4 25 | $304.3M | $275.7M | ||
| Q3 25 | $318.5M | $276.0M | ||
| Q2 25 | $315.7M | $278.0M | ||
| Q1 25 | $314.7M | $279.3M | ||
| Q4 24 | $323.9M | $281.2M | ||
| Q3 24 | $328.1M | $277.3M | ||
| Q2 24 | $320.7M | $275.2M | ||
| Q1 24 | $320.1M | $163.9M |
| Q4 25 | $3.3B | $311.8M | ||
| Q3 25 | $3.4B | $308.5M | ||
| Q2 25 | $3.4B | $309.0M | ||
| Q1 25 | $3.5B | $313.0M | ||
| Q4 24 | $3.6B | $318.6M | ||
| Q3 24 | $3.6B | $310.5M | ||
| Q2 24 | $3.8B | $305.5M | ||
| Q1 24 | $3.8B | $183.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $35.9M | $-1.1M |
| Free Cash FlowOCF − Capex | $34.9M | $-2.3M |
| FCF MarginFCF / Revenue | 133.3% | -6.9% |
| Capex IntensityCapex / Revenue | 4.0% | 3.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $58.2M | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.9M | $-1.1M | ||
| Q3 25 | $8.7M | $-1.2M | ||
| Q2 25 | $10.3M | $-4.4M | ||
| Q1 25 | $5.0M | $-8.8M | ||
| Q4 24 | $67.7M | $-4.3M | ||
| Q3 24 | $43.5M | $650.0K | ||
| Q2 24 | $8.1M | $-4.0M | ||
| Q1 24 | $8.3M | $-9.3M |
| Q4 25 | $34.9M | $-2.3M | ||
| Q3 25 | $8.5M | $-1.8M | ||
| Q2 25 | $10.2M | $-5.9M | ||
| Q1 25 | $4.7M | $-9.4M | ||
| Q4 24 | $66.5M | $-5.1M | ||
| Q3 24 | $43.4M | $-453.0K | ||
| Q2 24 | $8.1M | $-5.5M | ||
| Q1 24 | $8.1M | $-11.3M |
| Q4 25 | 133.3% | -6.9% | ||
| Q3 25 | 32.0% | -5.8% | ||
| Q2 25 | 40.4% | -17.6% | ||
| Q1 25 | 19.8% | -24.8% | ||
| Q4 24 | 287.5% | -12.7% | ||
| Q3 24 | 166.0% | -1.3% | ||
| Q2 24 | 39.6% | -15.9% | ||
| Q1 24 | 32.3% | -38.2% |
| Q4 25 | 4.0% | 3.5% | ||
| Q3 25 | 1.1% | 1.9% | ||
| Q2 25 | 0.6% | 4.6% | ||
| Q1 25 | 1.2% | 1.5% | ||
| Q4 24 | 5.3% | 2.1% | ||
| Q3 24 | 0.3% | 3.1% | ||
| Q2 24 | 0.2% | 4.4% | ||
| Q1 24 | 0.6% | 6.7% |
| Q4 25 | — | — | ||
| Q3 25 | 2.05× | — | ||
| Q2 25 | 2.90× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.70× | — | ||
| Q3 24 | 6.53× | — | ||
| Q2 24 | 2.88× | — | ||
| Q1 24 | 1.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCBP
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |